Milbemite for Dogs and Cats

What are the side effects you encounter while taking this medicine?  No   Yes

Milbemite for Dogs and Cats uses

• Description:
• Indications:
• Human warnings:
• Precautions:
• Adverse reactions:
• Dosage:
• Administration:
• Effectiveness:
• Safety:
• Storage conditions:
• How supplied:
• Milbemite for Dogs and Cats reviews

(0.1% Milbemite for Dogs and Cats)

Caution: U.S. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Description:

Milbemite for Dogs and Cats OTIC Solution is available in plastic dispensing tubes. Each plastic tube contains 0.25 mL of Milbemite for Dogs and Cats OTIC Solution as a 0.1% solution of Milbemite for Dogs and Cats. Milbemite for Dogs and Cats consists of the oxime derivatives of 5-didehydromilbemycins in the ratio of approximately 80% A4 (C₃₂H₄₅NO₇, MW 555.71) and 20% A₃ (C₃₁H₄₃NO₇, MW 541.68).

Indications:

Milbemite for Dogs and Cats OTIC Solution is indicated for treatment of ear mite (Otodectes cynotis) infestations in cats and kittens four weeks of age and older. Effectiveness is maintained throughout the life cycle of the ear mite.

Human Warnings:

Not for human use. Keep this and all drugs out of the reach of children.

Precautions:

The safe use of Milbemite for Dogs and Cats OTIC Solution in cats used for breeding purposes, during pregnancy, or in lactating queens, has not been evaluated.

Adverse Reactions:

No adverse reactions caused by Milbemite for Dogs and Cats OTIC Solution have been reported in controlled effectiveness studies in adult cats and kittens (4 weeks of age).

Dosage:

Milbemite for Dogs and Cats OTIC Solution should be administered topically into the external ear canal as the entire contents of a single-dose tube per ear. The volume delivered will be approximately 0.2 mL, with 0.05 mL residual volume remaining in dispensing tube. Repeat the treatment one time if necessary, based upon the ear mite life cycle and the response to treatment.

Administration:

Milbemite for Dogs and Cats OTIC Solution should be administered as one tube per ear as a single treatment. Each foil pouch contains two tubes of solution, one for each ear. Open the tube by pressing cap down firmly to break seal. Remove cap and check to be sure tip of tube is open. Squeeze the tube to administer the contents of one tube into each external ear canal. Massage the base of the ear for optimal distribution. In clinical field trials, ears were not cleaned and many animals still had debris in their ears at the end of the study. Cleaning of the external ear canal prior to treatment may be performed, but is not necessary to provide effectiveness.

Effectiveness:

The clinical effectiveness of Milbemite for Dogs and Cats 0.1% solution was evaluated in a placebo-controlled clinical field trial of client-owned cats. Otodectes cynotis infestation was diagnosed by direct microscopic visualization of ear swab debris. Test or placebo treatment was administered to both ears of the cat following the pre-treatment examination. Cats' ears were examined by ear swab microscopy at multiple intervals throughout the life cycle of the mite (up to day 30). Ninety-nine percent (99%) of the milbemycin oxime-treated group were ear mite negative at the microscopic exams.

Safety:

A study was conducted using otic doses of 0.1, 0.3 or 0.5% Milbemite for Dogs and Cats solutions administered once weekly for six applications in kittens that were 4 weeks of age at the initiation of the study. Otic doses of 0.1 and 0.3% did not produce adverse systemic or local effects. One kitten treated with 0.5% was lethargic 8 hours after the second treatment. The kitten was offered milk replacer and by 10 hours post-treatment it appeared normal. In this kitten, lethargy was not observed after subsequent treatments. A study was conducted to evaluate the safety of a 0.1% Milbemite for Dogs and Cats solution in adult cats. Topical doses at 1X, 3X or 5X the recommended dose applied in one ear did not produce adverse effects.

Storage Conditions:

Milbemite for Dogs and Cats OTIC Solution should be stored at room temperature, between 59° and 77°F (15-25°C).

How Supplied:

Milbemite for Dogs and Cats OTIC Solution is supplied in individual white polypropylene tubes, paired in a foil overlay pouch. The product is packaged in a box of 10 pouches of 2 tubes of 0.25 mL each.

Product of Japan

Manufactured for: Elanco US Inc.

Greenfield, IN 46140, USA

NADA #141-163, Approved by FDA.

Elanco, Milbemite for Dogs and Cats and the diagonal bar are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries or affiliates.

PA100047AMX

Milbemite for Dogs and Cats

OTIC Solution (0.1% Milbemite for Dogs and Cats)

A topical medication for the treatment of ear mite

(Otodectes cynotis) infestations in cats and kittens.

FOR USE IN CATS & KITTENS

FOUR WEEKS OF AGE AND OLDER

Net Contents:

10 pouches of

2 tubes of

0.25 mL each

Elanco

Keep out of the

reach of children.

YL100047AMX

Milbemite for Dogs and Cats

OTIC Solution

(0.1% milbemycin

oxime)

0.25mL

Milbemite for Dogs and Cats

OTIC Solution (0.1% Milbemite for Dogs and Cats)

For the treatment of ear mite (Otodectes cynotis)

infestations in cats and kittens.

FOR USE IN CATS & KITTENS FOUR WEEKS OF

AGE AND OLDER

Net Contents: 2 tubes of 0.25 mL each

HUMAN WARNINGS:

Not for human use. Keep this and all drugs out

of the reach of children.

CAUTION: Federal (USA) law restricts this drug

to use by or on the order of a licensed veterinarian.

Milbemite for Dogs and Cats pharmaceutical active ingredients containing related brand and generic drugs:

• Milbemycin Oxime

Milbemite for Dogs and Cats available forms, composition, doses:

• Solution; Otic; Milbemycin Oxime 0.1%

Milbemite for Dogs and Cats destination | category:

• Cats
• Dogs
• Veterinary; Pet Meds:

Milbemite for Dogs and Cats Anatomical Therapeutic Chemical codes:

• N/A

Milbemite for Dogs and Cats pharmaceutical companies:

• Novartis

References

1. Dailymed."MILBEMITE (MILBEMYCIN OXIME) SOLUTION [ELANCO US INC.]". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).

Frequently asked Questions

Can i drive or operate heavy machine after consuming Milbemite for Dogs and Cats?

Depending on the reaction of the Milbemite for Dogs and Cats after taken, if you are feeling dizziness, drowsiness or any weakness as a reaction on your body, Then consider Milbemite for Dogs and Cats not safe to drive or operate heavy machine after consumption. Meaning that, do not drive or operate heavy duty machines after taking the capsule if the capsule has a strange reaction on your body like dizziness, drowsiness. As prescribed by a pharmacist, it is dangerous to take alcohol while taking medicines as it exposed patients to drowsiness and health risk. Please take note of such effect most especially when taking Primosa capsule. It's advisable to consult your doctor on time for a proper recommendation and medical consultations.

Is Milbemite for Dogs and Cats addictive or habit forming?

Medicines are not designed with the mind of creating an addiction or abuse on the health of the users. Addictive Medicine is categorically called Controlled substances by the government. For instance, Schedule H or X in India and schedule II-V in the US are controlled substances.

Please consult the medicine instruction manual on how to use and ensure it is not a controlled substance.In conclusion, self medication is a killer to your health. Consult your doctor for a proper prescription, recommendation, and guidiance.

Review

sdrugs.com conducted a study on Milbemite for Dogs and Cats, and the result of the survey is set out below. It is noteworthy that the product of the survey is based on the perception and impressions of the visitors of the website as well as the views of Milbemite for Dogs and Cats consumers. We, as a result of this, advice that you do not base your therapeutic or medical decisions on this result, but rather consult your certified medical experts for their recommendations.

Visitor reports

Visitor reviews

There are no reviews yet. Be the first to write one!

Your name:  Email:  Spam protection:  < Type 23 here

The information was verified by Dr. Rachana Salvi, MD Pharmacology